&lt;i&gt;NFE2L2&lt;/i&gt;-Associated Ferroptosis Resistance Reshapes the Tumor Immune Microenvironment and Guides Therapeutic Strategies in Prostate Cancer. Here, NFE2L2 is linked to prostate cancer.